Sai Parenteral's
add_icon

Sai Parenteral's

540.85
-2.55
(-0.47%)
Market Cap
2,389.43 Cr
PE Ratio
115.49
Volume
58,240.00
Day High - Low
546.20 - 539.00
52W High-Low
706.00 - 400.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
2,389.43 Cr
EPS
4.36
PE Ratio
115.49
PB Ratio
4.89
Book Value
111.09
EBITDA
38.70
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
15.06
Debt to Equity
1.26
Forecast For
Actual

Company News

View All News
Caret
neutral
Sai Parenterals Limited plans to redirect unutilised IPO proceeds towards acquiring stakes in Saicriti Pharma and Prathyak Laboratories. The move aims to bypass regulatory hurdles in Hyderabad's core urban region.
positive
Sai Parenterals presents Q1FY26 results, outlining a ₹571 crore capex plan, Noumed integration, and proposed IPO proceeds variation for new injectable and R&D facilities.
positive
Sai Parenterals Ltd reported a 975% YoY surge in standalone net profit to ₹88.75 million for Q1FY27. The board also approved major acquisitions and IPO fund reallocation.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,902.40
#1 4,56,449.48
37.64
#1 61,673.90
12.69
#1 11,565
26.53
43.08
8,597.00
2,28,223.34
77.94
11,067.00
13.95
2,568
65.50
73.35
4,896.50
1,86,247.12
88.12
13,886.20
20.34
2,138
3.28
48.73
1,432.20
1,15,699.61
34.61
29,044.60
2.24
3,870
-39.18
45.95
1,120.00
1,12,698.21
24.08
27,657.90
17.64
5,026
-34.90
48.15
2,201.80
1,00,673.46
#1 18.15
29,038.90
#1 26.75
5,356
16.00
29.34
2,384.00
98,458.24
47.64
14,636.40
14.85
1,938
29.13
39.76
1,174.70
98,048.58
30.97
35,058.60
3.90
4,158
-69.10
43.08
1,802.00
97,282.16
90.34
6,867.80
22.01
890
#1 123.93
60.02
1,621.30
93,286.02
25.14
34,145.20
5.56
3,503
25.21
54.01
Growth Rate
Revenue Growth
132.74 %
Net Income Growth
-51.39 %
Cash Flow Change
211.39 %
ROE
36.78 %
ROCE
40.94 %
EBITDA Margin (Avg.)
-59.33 %

Quarterly Financial Results

Quarterly Financials
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
35
55
99
201
182
Expenses
29
42
100
172
155
EBITDA
6
13
-0
29
27
Operating Profit %
14 %
21 %
-4 %
13 %
13 %
Depreciation
2
1
6
8
8
Interest
3
2
5
8
9
Profit Before Tax
2
9
-12
12
10
Tax
1
3
-5
-1
2
Net Profit
1
6
-7
13
8
EPS in ₹
0.11
34.41
-2.22
4.02
1.79

Order Value Trend

FY 2026-27 order value₹5,409.00 Cr
FY 2026-276 Orders
Australia's leading pharmacy n...
48.07%
Australia's Leading Pharmacy N...
48.07%
PILL CORP, Bulacan, Philippine...
3.86%

Balance Sheet

Balance Sheet
2023
2024
2025
2026
Total Assets
134
268
272
1,424
Fixed Assets
45
70
53
451
Current Assets
82
187
200
822
Capital Work in Progress
2
0
1
212
Investments
0
0
0
172
Other Assets
88
198
219
0
Total Equity & Liabilities
134
268
272
1,424
Current Liabilities
77
153
162
573
Non Current Liabilities
26
39
14
357
Total Equity
32
76
96
491
Reserve & Surplus
24
61
80
469
Share Capital
7
13
13
22

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
-8
3
-2
Investing Activities
-19
-46
0
Operating Activities
-13
-30
33
Financing Activities
24
79
-36

Share Holding

% Holding
Sept 2025
Mar 2026
Apr 2026
Jun 2026
Promoter
61.23 %
51.16 %
51.16 %
51.16 %
FIIs
0.00 %
5.73 %
5.73 %
4.03 %
DIIs
0.00 %
12.86 %
12.86 %
8.53 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
22.67 %
22.67 %
25.33 %
Others
38.77 %
7.59 %
7.59 %
10.95 %
No of Share Holders
119
143
7,687
9,312

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
10 Sept 2026 587.50 541.40
23 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2026 478.60 486.70
11 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Aug 2026 554.90 587.50

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
Book Closure Intimation For 25Th Annual General Meeting2 days ago
Reg. 34 (1) Annual Report.2 days ago
Notice Of 25Th Annual General Meeting2 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome9 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation10 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.10 days ago
Announcement under Regulation 30 (LODR)-Change in Management10 days ago
Financial Results For The Quarter Ended 30.06.2026.10 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th August 2026.10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2026
Board Meeting Intimation for Meeting Proposed To Be Held On 11Th August 2026.Aug 04, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 18, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJul 06, 2026
Board Meeting Outcome for Outcome Of The Board MeetingJul 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 01, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 01, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 01, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2026
Closure of Trading WindowJun 29, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 29, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2026
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 23, 2026
Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31.03.2026May 23, 2026
Un Audited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2025May 23, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 23.05.2026May 23, 2026
Board Meeting Intimation for The Notice Of Board MeetingMay 19, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2026
Results-Delay in Financial ResultsApr 22, 2026
Board Meeting Outcome for Outcome Of Board MeetingApr 20, 2026
Board Meeting Intimation for INTIMATION OF BOARD MEETING WHICH IS PROPOSED TO BE HELD ON 20TH OF APRIL 2026Apr 14, 2026
Closure of Trading WindowApr 06, 2026
Intimation Under Regulation 30(5) Of SEBIApr 06, 2026
Listing of Equity Shares of Sai Parenterals LtdApr 02, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Healthcare Fund Direct-Growth
0.97%
56650
0.97%
0.97%
Bandhan Large & Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Midcap Fund Direct-Growth
0.05%
0
0.00%
0.05%
Quant Momentum Fund Direct-Growth
0.00%
0
0.00%
-0.92%
Quant Small Cap Fund Direct Plan-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
45.43
ATR(14)
Less Volatile
22.26
STOCH(9,6)
Neutral
39.50
STOCH RSI(14)
Neutral
40.82
MACD(12,26)
Bearish
-1.02
ADX(14)
Weak Trend
23.92
UO(9)
Bearish
40.18
ROC(12)
Uptrend And Accelerating
4.80
WillR(14)
Neutral
-63.96